BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Weber A, Landrock S, Schneider J, Stangl M, Neu B, Born P, Classen M, Rösch T, Schmid RM, Prinz C. Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma. World J Gastroenterol 2007; 13(9): 1422-1426 [PMID: 17457974 DOI: 10.3748/wjg.v13.i9.1422]
URL: https://www.wjgnet.com/1007-9327/full/v13/i9/1422.htm
Number Citing Articles
1
Daniele Gehlen Klaus, Diélly Cunha de Carvalho, Marília Granzotto Volpato, Alita Thizon Menegali, Jaime César Gelosa Souza, Orli Franzon. Derivação biliodigestiva no tratamento do tumor de KlatskinABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2009; 22(2): 133 doi: 10.1590/S0102-67202009000200015
2
Ban S. Lee, Jin‐Hyeok Hwang, Sang H. Lee, Sang E. Jang, Dong‐Won Ahn, Dae W. Hwang, Jai Y. Cho, Yoo‐Seok Yoon, Ho‐Seong Han, Soyeon Ahn. Older Adults with Biliary Tract Cancer: Treatment and PrognosisJournal of the American Geriatrics Society 2012; 60(10): 1862 doi: 10.1111/j.1532-5415.2012.04163.x
3
Kyun Woo Park, Eun-Seon Jung, Dong-Gu Kim, Young-Kyung Yoo, Tae-Ho Hong, In Seok Lee, Yoon Ho Koh, Ji-Hoon Kim, Myung Ah Lee. ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic CholangiocarcinomaCancer Research and Treatment 2013; 45(1): 63 doi: 10.4143/crt.2013.45.1.63
4
Mustafa ÇELİK, Emrah ALPER, Behlül BAYDAR, Mahmut ARABUL, Zafer BUYRAÇ, Fatih CANTÜRK, Altay KANDEMİR, Serdar AKÇA, Belkıs ÜNSAL. İnoperabl Klatskin tümörlü hastaların endoskopik tedavi ile uzun dönem sonuçlarıEndoskopi Gastrointestinal 2015; 19(1): 1 doi: 10.17940/endoskopi.74870
5
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 587 doi: 10.1007/978-3-319-26956-6_30
6
Zheng Shi, Ming-Zhi Yang, Qing-Liang He, Rong-Wen Ou, You-Ting Chen. Addition of hepatectomy decreases liver recurrence and leads to long survival in hilar cholangiocarcinomaWorld Journal of Gastroenterology 2009; 15(15): 1892-1896 doi: 10.3748/wjg.15.1892
7
Mario Fernández-Ruiz, Juan-Manuel Guerra-Vales, Francisco Colina-Ruizdelgado. Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinomaWorld Journal of Gastroenterology 2009; 15(42): 5279-5286 doi: 10.3748/wjg.15.5279
8
Mohamed Akoad, Roger Jenkins. Proximal Biliary MalignancySurgical Clinics of North America 2008; 88(6): 1409 doi: 10.1016/j.suc.2008.07.012
9
Vlad-Ionuţ Nechita, Emil Moiş, Luminiţa Furcea, Mihaela-Ancuţa Nechita, Florin Graur. Klatskin Tumor: A Survival Analysis According to Tumor Characteristics and Inflammatory RatiosMedicina 2022; 58(12): 1788 doi: 10.3390/medicina58121788
10
A. S.-Y. Leong, C. Pairojkul. Hilar Cholangiocarcinoma2013; : 25 doi: 10.1007/978-94-007-6473-6_3
11
Abhijeet Waghray, Anastasia Sobotka, Carlos Romero Marrero, Bassam Estfan, Federico Aucejo, KV Narayanan Menon. Serum albumin predicts survival in patients with hilar cholangiocarcinomaGastroenterology Report 2016; : gow021 doi: 10.1093/gastro/gow021
12
Joshua Y Kwon, Paul J Nietert, Don C Rockey. Hyperbilirubinemia in hospitalized patients: Etiology and outcomesJournal of Investigative Medicine 2023; 71(7): 773 doi: 10.1177/10815589231180498
13
Hong-Ming Tsai, Chiao-Hsiung Chuang, Xi-Zhang Lin, Chiung-Yu Chen. Factors relating to the short term effectiveness of percutaneous biliary drainage for hilar cholangiocarcinomaWorld Journal of Gastroenterology 2009; 15(41): 5206-5210 doi: 10.3748/wjg.15.5206
14
G. Schachschal, S. Jonas, T. Rösch. Endoscopy 2006 — Update and Live Demonstration2008; : 55 doi: 10.1007/978-1-4020-9148-3_7
15
Anne Horgan, Jennifer Knox, Priya Aneja, Lisa Le, Elizabeth McKeever, Mairead McNamara. Patterns of care and treatment outcomes in older patients with biliary tract cancerOncotarget 2015; 6(42): 44995 doi: 10.18632/oncotarget.5707
16
Jongha Park, Myung-Hwan Kim, Kyu-pyo Kim, Do Hyun Park, Sung-Hoon Moon, Tae Jun Song, Junbum Eum, Sang Soo Lee, Dong Wan Seo, Sung Koo Lee. Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational StudyGut and Liver 2009; 3(4): 298 doi: 10.5009/gnl.2009.3.4.298
17
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_30-1
18
Fu-Xiang Yu, Shi-Qiang Ji, Long-Feng Su, Sheng-Chu Zhang, Qi-Yu Zhang. Effectiveness and Safety of Preoperative Percutaneous Transhepatic Cholangiodrainage With Bile Re-infusion in Patients With Hilar Cholangiocarcinoma: A Retrospective Controlled StudyThe American Journal of the Medical Sciences 2013; 346(5): 353 doi: 10.1097/MAJ.0b013e3182755de6
19
Ali Siddiqui, Haroon Shahid, Avik Sarkar, Kristen Cox, Thomas E. Kowalski, David E. Loren, Ashish Sharma, Patrick Laing, Madeline Birch, Douglas G. Adler. Stage of Hilar Cholangiocarcinoma Predicts Recurrence of Biliary Obstruction in Patients With Metal StentsClinical Gastroenterology and Hepatology 2013; 11(9): 1169 doi: 10.1016/j.cgh.2013.05.035
20
Michael G. House, Michael I. D’Angelica, William R. Jarnagin. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract2012; : 771 doi: 10.1016/B978-1-4377-1454-8.00111-9
21
Andreas Weber, Claus von Weyhern, Falko Fend, Jochen Schneider, Bruno Neu, Alexander Meining, Hans Weidenbach, Roland M Schmid, Christian Prinz. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinomaWorld Journal of Gastroenterology 2008; 14(7): 1097-1101 doi: 10.3748/wjg.14.1097
22
J.J. Kloek, F.J. Ten Kate, O.R.C. Busch, D.J. Gouma, T.M. Van Gulik. Surgery for extrahepatic cholangiocarcinoma: predictors of survivalHPB 2008; 10(3): 190 doi: 10.1080/13651820801992575
23
Ursula Dahlstrand, Gabriel Sandblom, Lars-Gunnar Eriksson, Rickard Nyman, Ib Christian Rasmussen. Primary patency of percutaneously inserted self-expanding metallic stents in patients with malignant biliary obstructionHPB 2009; 11(4): 358 doi: 10.1111/j.1477-2574.2009.00069.x
24
Wen-long Yu, Wen-ming Cong, Yongjie Zhang, Ying Chen, Fei Wang, Guanzhen Yu. Overexpression of ATA1/SLC38A1 Predicts Future Recurrence and Death in Chinese Patients with Hilar CholangiocarcinomaJournal of Surgical Research 2011; 171(2): 663 doi: 10.1016/j.jss.2010.03.049
25
E Friend, G Yadegarfar, C Byrne, C D Johnson, O Sezer, S Pucciarelli, S P Pereira, W-C Chie, A Banfield, J K Ramage. Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21British Journal of Cancer 2011; 104(4): 587 doi: 10.1038/sj.bjc.6606086
26
Marcus Wiedmann, Helmut Witzigmann, Joachim Mössner. Clinical Hepatology2010; : 1519 doi: 10.1007/978-3-642-04519-6_62
27
A. G. SINGAL, M. O. RAKOSKI, R. SALGIA, S. PELLETIER, T. H. WELLING, R. J. FONTANA, A. S. LOK, J. A. MARRERO. The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centreAlimentary Pharmacology & Therapeutics 2010; 31(6): 625 doi: 10.1111/j.1365-2036.2009.04218.x
28
Mayura M. Desai, Batbayar Tumurbataar, Yueqing Zhang, Lee-Nien Lillian Chan, Jiaren Sun, Teh-sheng Chan. Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic miceTransgenic Research 2011; 20(6): 1273 doi: 10.1007/s11248-011-9494-x